Robert Warburton, PhD
Dr. Warburton completed his Ph.D. in Biochemistry at Duquesne University in the laboratory of Dr. David W. Seybert and then did his Postdoc in the laboratory of Dr. Jeffrey A. Frelinger. His research interests are in proteomics, particularly in the study of point mutations and Structure/Function relationships.
Dr. Warburton is currently engaged in research, funded by the NIH, in collaboration with faculty in the School of Medicine at West Virginia University. The project is to model tumors to determine better immunotherapy methodology to treat aggressive triple negative breast cancers.
CHEM 329, CHEM 329L, CHEM 330, CHEM 330L, CHEM 101, CHEM 101L, CHEM 102, CHEM 102L
- Warburton RJ (2006) A journey out of Darkness PDB Newsletter, 31, Research Collaboratory for Structural Bioinformatics, Fall Edition.
- Melissa Pegues, Nicholas Drozda, Seung-yun Kim, and Robert Warburton. Modeling and Simulation of Biochemical Processes using Petri Nets: Steroid Hormone Biosynthesis and Action of Aldosterone. Bioinformatics and Computational Biology (BICoB) Conference, New Orleans, LA, in March 2011
- Warburton, R.J., Kalathas, N.G., Corey, K. and Sheil, J.M. (2005) “Proteomics of H-2Kb and H-2Kbm Mutant Antigenic Peptides.” WV-INBRE Summer Research Symposium, Marshall University.
- Eric Goff, Shannon Fenton, Jeremiah Miller, Robert Warburton, David Klinke, & Qing Wang (2015). Developing a three-dimensional cell culture assay to assess the effects of Paclitaxel on the human breast cancer cell line Hs578T. WV-INBRE Summer Research Symposium, Marshall University.